Cargando…
Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Alzheimer disease (AD) is a chronic neurodegenerative disease that accounts for 60–70% of dementia and is the sixth leading cause of death in the United States. The pathogenesis of this debilitating disorder is still not completely understood. New insights into the pathogenesis of AD are needed in o...
Autores principales: | Wei, Zenghui, Koya, Jagadish, Reznik, Sandra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326507/ https://www.ncbi.nlm.nih.gov/pubmed/34349617 http://dx.doi.org/10.3389/fnins.2021.687157 |
Ejemplares similares
-
Insulin Resistance in Alzheimer's Disease
por: Ferreira, Laís S. S., et al.
Publicado: (2018) -
Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
por: Neth, Bryan J., et al.
Publicado: (2017) -
N,N-dimethylacetamide targets neuroinflammation in Alzheimer’s disease in in-vitro and ex-vivo models
por: Wei, Zeng-Hui, et al.
Publicado: (2023) -
The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer’s Pathogenesis via Specific Pathways
por: Wu, Hongle, et al.
Publicado: (2022) -
Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021)